Opendata, web and dolomites

GOTBONE TERMINATED

Novel mechanisms of site-specific regulation of bone strength for the prevention of osteoporotic fractures: a translational project

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 GOTBONE project word cloud

Explore the words cloud of the GOTBONE project. It provides you a very rough idea of what is the project "GOTBONE" about.

thickness    modified    skills    morphogenetic    representing    reducing    osteoporotic    regulating    lifetime    remaining    murine    osteoporosis    locus    academic    genetic    performed    therapies    fracture    economic    40    lipase    bmd    medicine    impaired    burden    interaction    spectrum    site    sustain    health    complementary    prevention    regulates    osteoarthritis    excellence    population    background    biomarkers    supervisor    dependent    men       women    epidemiological    cohort    mineral    lab    vertebral    15    density    3010    basis    cortical    collaborations    least    volumetric    regulator    translate    mortality    antagonist    genetically    2014    assistant    human    protein    professor    predicts    preclinical    mechanisms    nature    biology    fragility    special    fractures    translational    serum    models    wnt16    microarchitecture    huge    regulation    bone    trabecular    drugs    rheumatology    notum    cell    prospective    added    fellowship    determinants    cultures    wnt    risk    career    clinical    hip    grem2   

Project "GOTBONE" data sheet

The following table provides information about the project.

Coordinator
GOETEBORGS UNIVERSITET 

Organization address
address: VASAPARKEN
city: GOETEBORG
postcode: 405 30
website: www.gu.se

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website https://gup.ub.gu.se/publication/269257
 Total cost 185˙857 €
 EC max contribution 185˙857 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2019-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    GOETEBORGS UNIVERSITET SE (GOETEBORG) coordinator 185˙857.00

Map

 Project objective

Osteoporosis is a major health concern characterized by reduced bone mineral density (BMD) and impaired microarchitecture leading to increased risk of fractures and mortality, especially at the hip. At least 40% of women and 15% of men will sustain one or more fragility fractures in their remaining lifetime, representing a huge economic burden in Europe. Currently available osteoporosis drugs are effective in reducing vertebral fracture risk (dependent on trabecular bone) while less effective for non-vertebral and hip fracture risk (dependent on cortical bone). This proposal aims to identify novel mechanisms regulating site-specific fracture risk, on the basis of recent human genetic findings on the determinants of cortical bone thickness (WNT16 locus) and trabecular volumetric BMD (GREM2 locus). This translational research program will study the role of the WNT lipase NOTUM in the regulation of cortical bone thickness via its interaction with WNT16, a key regulator of cortical bone identified by the proposed supervisor (Nature Medicine 2014). We will next study how the Bone Morphogenetic Protein antagonist GREM2 regulates trabecular BMD. These studies will be performed using genetically modified murine models and human cell-cultures systems. Finally, in a prospective population-based cohort study (n=3010), we will test if serum level of NOTUM predicts the risk of fractures. Our long term goal is to translate these findings into novel biomarkers and more effective therapies for the prevention of osteoporotic fractures. The applicant is an Assistant Professor of Rheumatology with a special clinical focus on osteoporosis and a complementary preclinical research background in osteoarthritis but not osteoporosis. This fellowship in a lab of excellence in the field of translational osteoporosis research will enhance his skills in both bone biology and epidemiological studies and will provide a huge added-value to his academic career with a spectrum of new collaborations.

 Publications

year authors and title journal last update
List of publications.
2018 Thomas Funck-Brentano, Karin H Nilsson, Robert Brommage, Petra Henning, Ulf H Lerner, Antti Koskela, Juha Tuukkanen, Martine Cohen-Solal, Sofia Movérare-Skrtic, Claes Ohlsson
Porcupine inhibitors impair trabecular and cortical bone mass and strength in mice
published pages: 13-23, ISSN: 0022-0795, DOI: 10.1530/JOE-18-0153
Journal of Endocrinology 238/1 2019-06-11

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GOTBONE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GOTBONE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

NarrowbandSSL (2019)

Development of Narrow Band Blue and Red Emitting Macromolecules for Solution-Processed Solid State Lighting Devices

Read More  

5G-ACE (2019)

Beyond 5G: 3D Network Modelling for THz-based Ultra-Fast Small Cells

Read More  

TRANSMODERN (2019)

Untranslatable Modernity: Modern Literary Theory from Europe to Iran

Read More